Ironwood Enters into Definitive Agreement to Acquire VectivBio

20222023

May 22

Written By Guest User

Guest User

enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company

AMOLYT PHARMA ANNOUNCES $138 MILLION SERIES C FINANCING LED BY SOFINNOVA PARTNERS AND CO-LED BY INTERMEDIATE CAPITAL GROUP